ID

24846

Beschreibung

Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876

Link

https://clinicaltrials.gov/ct2/show/NCT00291876

Stichworte

Versionen (1)
  1. 19.08.17 19.08.17 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

19. August 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

GSK Hepatitis A Vaccine Tracking Document Long Term Follow-up NCT00291876

Englisch

GSK Hepatitis A Vaccine Tracking Document Long Term Follow-up NCT00291876

1 Formulare  
Study administration
Beschreibung

Study administration

Center
Beschreibung

Center

Datentyp

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Long Term Follow-up
Beschreibung

Long Term Follow-up

Subject number of previous study
Beschreibung

Subject number of previous study

Datentyp

text

Alias
UMLS CUI [1,1]
C2348585
UMLS CUI [1,2]
C2242969
Subject initials first name family name
Beschreibung

Subject initials

Datentyp

text

Alias
UMLS CUI [1]
C2986440
Date of birth
Beschreibung

Date of birth

Datentyp

date

Maßeinheiten
  • day month year
Alias
UMLS CUI [1]
C0421451
day month year
Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
Beschreibung

study subject participation subject

Datentyp

integer

Alias
UMLS CUI [1]
C2348568
If answer is 3., choose
Beschreibung

study subject participation status adverse event

Datentyp

integer

Alias
UMLS CUI [1]
C2348568
please specify
Beschreibung

study subject participation status specify

Datentyp

text

Alias
UMLS CUI [1]
C2348568
Date of contact
Beschreibung

Date of contact

Datentyp

date

Alias
UMLS CUI [1]
C0805839
Investigator
Beschreibung

Investigator

Investigator name
Beschreibung

Investigator name

Datentyp

text

Alias
UMLS CUI [1]
C2826892
Signature
Beschreibung

Signature

Datentyp

text

Alias
UMLS CUI [1]
C1519316
Date
Beschreibung

Signature date

Datentyp

date

Alias
UMLS CUI [1]
C0807937
Zum Seitenanfang zurückkehren

Ähnliche Modelle

GSK Hepatitis A Vaccine Tracking Document Long Term Follow-up NCT00291876

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Study administration
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Item Group
Long Term Follow-up
Subject number of previous study
Item
Subject number of previous study
text
C2348585 (UMLS CUI [1,1])
C2242969 (UMLS CUI [1,2])
Subject initials
Item
Subject initials first name family name
text
C2986440 (UMLS CUI [1])
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
integer
C2348568 (UMLS CUI [1])
study subject participation subject
Code List
Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
CL Item
1. Subject not eligible (1)
CL Item
2. Subject lost to follow-up or not reached (2)
CL Item
3. Subject eligible but not willing to participate due to: (3)
CL Item
4. Subject eligible and agreed to participate in the (4)
CL Item
long-term follow-up study (5)
Item
If answer is 3., choose
integer
C2348568 (UMLS CUI [1])
study subject participation subject
Code List
If answer is 3., choose
CL Item
adverse events, or serious adverse event: (1)
CL Item
other: (2)
study subject participation status specify
Item
please specify
text
C2348568 (UMLS CUI [1])
Date of contact
Item
Date of contact
date
C0805839 (UMLS CUI [1])
Item Group
Investigator
Investigator name
Item
Investigator name
text
C2826892 (UMLS CUI [1])
Signature
Item
Signature
text
C1519316 (UMLS CUI [1])
Signature date
Item
Date
date
C0807937 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video